Inam Butt and the Doping Case: When a Medical Form Missed a Beat

In a small room in Nha Trang, I reopened a brief dispatch from Islamabad. Two lines of text, no images, no match action. Inam Butt — a wrestler who once won the beach wrestling world championship — is waiting for a ruling from the International Testing Agency (ITA) after a doping violation. I had watched him compete through grainy livestreams, where sand blew into the lens and referees had to shout over the surf. He won with tidy hip throws, the kind of technique my Japanese coaches called striking the centre before the opponent could breathe. This time, his opponent is a rulebook more than two hundred pages thick, and a medical form that missed its deadline.

The story, according to sources in Pakistan, revolves around an eye condition. Inam Butt used medication to treat his eyes, and that medication sits on WADA's prohibited list. He did not obtain a Therapeutic Use Exemption (TUE) in time before using it. The International Testing Agency accepted the medical explanation — the drug was for treatment, not for performance. What remains is the procedural fault: the TUE application arrived late. A ruling is expected within a week, with a suspension of roughly two months, backdated to April. The silver medal from the Asian Beach Games in April is expected to be stripped. Before any formal ruling, Butt voluntarily stepped down as Secretary General of the Pakistan Wrestling Federation (PWF) and as Chairman of the Pakistan Olympic Association (POA) Athletes Commission.

I have followed the Asian Beach Games from the Bay of Bengal to Colombo, from Colombo to Phuket. Beach wrestling is a young discipline within the United World Wrestling (UWW) system. Far fewer nations enter than in freestyle or Greco-Roman. A world title here carries real value, but the competitive pyramid is much narrower than an Olympic honour. That matters when reading this case: Inam Butt is not a global media star; he is a veteran athlete shifting toward national-team coaching and administrative roles. A place at the Asian Games in Japan is the biggest remaining target on his competitive path.

Within the reporting itself sits a contradiction worth unpicking. On one hand, sources say Butt did not obtain the TUE in time. On the other, the same sources say the ITA permitted him to use the medication for a one-year period. Both can only be true if the permit was granted retroactively, or if it covered a different window and a different substance than the use that triggered the case. This is the crux the media rarely bothers to dissect, because it is less gripping than the question of medication versus cheating. The heart of this case lies in procedure, not in the substance.

The second point: doping law applies strict liability. However readily authorities accept that a medication was for the eyes, the medal can still be stripped, because forfeiture attaches to the presence of a banned substance in the sample, not to intent. This is where most fans misread the situation. They assume that being cleared as therapeutic equals being cleared of the charge. In practice, the two are entirely different. A suspension may be cut to a few months, or even reduced to a reprimand, but the silver medal is almost certainly gone for good.

From the Beat Keeper's vantage point, the most telling element here is not Butt himself. It is that one person simultaneously holds three roles: competing athlete, national-team coach, and federation official. When a doping case lands, those three roles overlap to create a structural conflict of interest. He is the subject of the investigation and, at the same time, holds a seat in the governing body responsible for overseeing that very investigation. No one needs to do anything wrong; the structure sours on its own. His voluntary withdrawal was a technical act, clearing a table before the glass tips over. But it also shows he understood the structure, and understood that to protect the federation he had to leave the seat before being asked to leave it.

This structural problem is not Pakistan's alone. It is the signature of federations with a thin talent pool. There, the same small group rotates through the titles: athlete, coach, referee, secretary, president. A country with few elite athletes is forced to recycle its people. And when one link in that chain is caught in an inquiry, the whole system wobbles. The story does not end at a single medal.

Pakistani media are framing the case as relief drawing near: a short suspension, honour preserved, an Asian Games place retained. That framing invites fans to assume the matter is settled. A man once called a world champion, now publicly tied to the phrase doping case, has crossed a line no ruling can erase. That headline style favours the athlete, but it quietly pushes a drier truth out of frame: the entire narrative rests on unnamed sources, not yet confirmed by the ITA. The most dangerous thing in a doping case is not the penalty, but the label that stays after the penalty ends.

I am not naive enough to dismiss the seriousness of banned substances. But after years spent on the edge of sports investigations, I keep seeing one pattern: small federations lack a dedicated legal department. They lack someone to remind athletes that every new medication, every new prescription, must be checked against the prohibited list before the first pill enters the body. Inam Butt was treating his eyes. A man treating his eyes is surely not thinking about performance. But that assumption did not save the medal.

The truest pulse is not in the stands; it beats under the feet of early-morning training sessions. There, an athlete learns that discipline does not stop at the mat. It extends to reading the label before swallowing. The ITA ruling will arrive within days. The lesson stays far longer.